Klaria Pharma Holding AB (publ.) reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported revenue was SEK 0.371 million compared to SEK 31.31 million a year ago. Net loss was SEK 20.26 million compared to net income of SEK 16.71 million a year ago.

Basic loss per share from continuing operations was SEK 0.37 compared to basic earnings per share from continuing operations of SEK 0.32 a year ago.